Company Profiles

driven by the PitchBook Platform

Azure Biotech

Azure Biotech
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Conv. Debt LATEST DEAL TYPE
$355K LATEST DEAL AMOUNT
Description

Developer of a drug for treatment of osteoporosis in women. The company is focused on women's health and is involved in developing a new formulation of lasofoxifene which is used for treatment of osteoporosis and other diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Primary Office
  • 111 South West Harrison Street
  • Suite 23C
  • Portland, OR 97201
  • United States

+1 (917) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Azure Biotech’s full profile, request a free trial.

Azure Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Convertible Debt 07-Jan-2015 $355K 00000 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Azure Biotech Executive Team (4)

Name Title Board
Seat
Contact
Info
David Thompson President & Board Member
Susan Levinson Ph.D Co-Founder & Board Member
Valerie Ceva Co-Founder, Treasurer, Secretary & Board Member

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Azure Biotech Board Members (4)

Name Representing Role Since Contact
Info
David Thompson Azure Biotech President & Board Member 000 0000
Steven Goldstein MD Azure Biotech Board Member 000 0000
Susan Levinson Ph.D Azure Biotech Co-Founder & Board Member 000 0000
Valerie Ceva Azure Biotech Co-Founder, Treasurer, Secretary & Board Member 000 0000